Salubris Biotherapeutics

SalubrisBio (a subsidiary of Salubris Pharmaceuticals Co Ltd) headquartered in Gaithersburg, Maryland was established in 2016 and is focused on the discovery and development of novel biologic therapeutics in the oncology, cardiovascular and metabolic disease therapy areas.In March 2023, the company announced that it received $35 million in financing from China-based Shenzhen Salubris Pharmaceuticals Co Ltd.In March 2022, Salubris Biotherapeutics Inc received $32 million in financing from Shenzhen Salubris Pharmaceuticals Co., Ltd